You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin dose

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Time in Range, Artificial Intelligence, Insulin Therapy Trial in Jingan (Wechat program)

Recruiting
  • Time in Range
  • +2 more
  • Wechat program
  • Shanghai, Shanghai, China
    Xiaolong Zhao
Oct 21, 2022

Healthy Trial in Saint Paul (Low dose Regular Insulin, High dose Regular insulin)

Recruiting
  • Healthy
  • Low dose Regular Insulin
  • High dose Regular insulin
  • Saint Paul, Minnesota
    HealthPartners Neuroscience Center
May 23, 2023

Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration Trial (High-Dose Insulin Therapy)

Not yet recruiting
  • Liver Dysfunction
  • +2 more
  • High-Dose Insulin Therapy
  • (no location specified)
Nov 6, 2023

Healthy Trial in Ann Arbor (Intranasal insulin)

Recruiting
  • Healthy
  • Intranasal insulin
  • Ann Arbor, Michigan
    University of Michigan
Nov 16, 2023

Diabetic Ketoacidosis Trial in Colombes (Insulin 0.05 IU/kg/h, Insulin 0.10 IU/kg/h)

Recruiting
  • Diabetic Ketoacidosis
  • Insulin 0.05 IU/kg/h
  • Insulin 0.10 IU/kg/h
  • Colombes, France
    Louis Mourier Hospital
Jan 19, 2023

Type 2 Diabetes Trial in Nanjing (Tirzepatide, Insulin Glargine)

Recruiting
  • Type 2 Diabetes Mellitus
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Sep 21, 2022

Diabetes Type 2 - Insulin-Treated Trial in Pittsburgh (Smartphone application and web portal, Standard Insulin Therapy

Active, not recruiting
  • Diabetes Mellitus Type 2 - Insulin-Treated
  • Smartphone application and web portal
  • Standard Insulin Therapy Education
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Jan 6, 2023

Type 1 Diabetes Trial in Kansas City (LOAN2DOSE and COIN2DOSE)

Recruiting
  • Type 1 Diabetes
  • LOAN2DOSE and COIN2DOSE
  • Kansas City, Kansas
    Children's Mercy Kansas City
Mar 25, 2022

Out-Of-Hospital Cardiac Arrest, Healthy Trial in Ann Arbor (Intranasal insulin)

Completed
  • Out-Of-Hospital Cardiac Arrest
  • Healthy
  • Intranasal insulin
  • Ann Arbor, Michigan
    University of Michigan
Oct 13, 2022

Type 1 Diabetes, Type 2 Diabetes, Hyperglycemia Trial in Winston-Salem (Libre 2.0 CGM in patients taking subcutaneous insulin

Not yet recruiting
  • Type 1 Diabetes Mellitus
  • +2 more
  • Libre 2.0 CGM in patients taking subcutaneous insulin with concomitant high dose glucocorticoids
  • Winston-Salem, North Carolina
    WakeForest University Health Sciences
May 11, 2023

Type 1 Diabetes Trial (HDV-Insulin Lispro)

Not yet recruiting
  • Type 1 Diabetes
  • HDV-Insulin Lispro
  • (no location specified)
Jan 9, 2023

Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Multiple Dose Insulin Therapy
  • Personalized treatment
  • (no location specified)
Nov 18, 2023

Type 1 Diabetes Trial in Liverpool (Active Breaks)

Recruiting
  • Type 1 Diabetes
  • Active Breaks
  • Liverpool, United Kingdom
    Liverpool John Moores University
Jan 20, 2023

Insulin Resistance Trial in Christchurch (TLC-3595 Dose 1, TLC-3595 Dose 2, Placebo)

Not yet recruiting
  • Insulin Resistance
  • TLC-3595 Dose 1
  • +2 more
  • Christchurch, New Zealand
    New Zealand Clinical Research
Dec 16, 2022

Type 1 Diabetes Trial (Coin2Dose)

Not yet recruiting
  • Type 1 Diabetes
  • Coin2Dose
  • (no location specified)
Nov 22, 2022

Glucose, High Blood Trial in Palm Beach Gardens (Human Insulin, Finger-actuated, Metered Pump Sprayer)

Not yet recruiting
  • Glucose, High Blood
  • Human Insulin
  • Finger-actuated, Metered Pump Sprayer
  • Palm Beach Gardens, Florida
    Langford Research Institute
Aug 3, 2022

Insulin Trial in Yangzhou (Glucose insulin potassium)

Recruiting
  • Insulin
  • Glucose insulin potassium
  • Yangzhou, Jiangsu, China
    the Affiliated Hospital of Yangzhou University, Yangzhou Univers
Jul 17, 2022

Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Guangzhou (CSII with formula-based initial insulin regimen,

Recruiting
  • Diabetes Mellitus
  • +4 more
  • CSII with formula-based initial insulin regimen
  • CSII with weight-based initial insulin regimen
  • Guangzhou, Guangdong, China
    endocrinology department of the first affiliated hospital of Sun
Oct 8, 2021

PreDiabetes Trial in Singapore (Single dose of 75 grams glucose in 200ml water)

Not yet recruiting
  • PreDiabetes
  • Single dose of 75 grams glucose in 200ml water
  • Singapore, Singapore
    Human Development Research Centre, SICS, A*STAR
Nov 6, 2023

Type 2 Diabetes Trial in Chengdu (Insulin degludec injection, RD15003, Insulin degludec, Tresiba)

Completed
  • Type 2 Diabetes
  • Insulin degludec injection, RD15003
  • Insulin degludec, Tresiba
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Oct 7, 2022

Type 1 Diabetes Trial in Montreal (14-day outpatient intervention)

Completed
  • Type 1 Diabetes
  • 14-day outpatient intervention
  • Montreal, Quebec, Canada
    Clinique Médicale Hygea
Oct 6, 2022

Low Fat Meal - Unadjusted Insulin Dose, High Fat Meal - Unadjusted Insulin Dose, High Fat Meal - Adjusted Insulin Dose +30

Completed
  • Low Fat Meal - Unadjusted Insulin Dose
  • +3 more
  • Meal composition
  • Rapid-Acting Insulin Dose
  • (no location specified)
Mar 2, 2021

Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Trial in New York (Diazoxide oral suspension, 1 mg per

Recruiting
  • Hyperinsulinemia
  • +3 more
  • Diazoxide oral suspension, 1 mg per kg per dose
  • +3 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 6, 2023

Chronic Kidney Diseases Trial in Cairo (Glargine, normal saline)

Recruiting
  • Chronic Kidney Diseases
  • Cairo, Egypt
    Ain Shams University
Jun 6, 2022

Type1 Diabetes Trial in Neuss (Insulin glulisine (U300), Insulin glulisine, Insulin aspart)

Completed
  • Type1 Diabetes Mellitus
  • Insulin glulisine (U300)
  • +6 more
  • Neuss, Germany
    Investigational Site Number 276001
Apr 21, 2022